Best Practices of Downstream Protein Purification and Product Concentration
Posted on October 14, 2022
Krishnamurthy Venkatesan, Downstream MSAT Lead, Senior Director
Biocon Biologics
Introduction Drug development for therapeutics has been a key aspect to enhance global healthcare through innovative and affordable biopharmaceuticals for patients. In the process of drug development, purification of the product and manufacturing forms the critical part of the journey to achieve the...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
